Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Net Debt / (EBITDA-CAPEX)

Albireo Pharma Inc Net Debt / (EBITDA-CAPEX) Chart (ALBO)

Albireo Pharma Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2015 to 2020.
  • Albireo Pharma Inc Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $2m a 11.51% increase of 0m year over year
  • Albireo Pharma Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $2m a -18.31% decrease of 0m year over year
  • Albireo Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $2m a -106.83% decrease of -2m from 2018
  • Albireo Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $4m a 56.37% increase of 2m from 2017
  • Albireo Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $2m a -113.77% decrease of -2m from 2016
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO Net Debt / (EBITDA-CAPEX) Data

06/2020$2m
03/2020$1m
12/2019$3m
09/2019$2m
06/2019$3m
03/2019$2m
12/2018$3m
09/2018$3m
06/2018$4m
03/2018$84m

Annual ALBO Net Debt / (EBITDA-CAPEX) Data

2019$2m
2018$4m
2017$2m
2016$4m
2015$0m
2014$0m